Your browser doesn't support javascript.
loading
Synthesis and vectorial functionalisation of pyrazolo[3,4-c]pyridines.
Bedwell, Elizabeth V; da Silva Emery, Flavio; Clososki, Giuliano C; Steel, Patrick G.
Afiliação
  • Bedwell EV; Department of Chemistry, University of Durham South Road Durham DH1 3LE UK p.g.steel@durham.ac.uk.
  • da Silva Emery F; Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Departamento de Ciências Farmacêuticas, Universidade de São Paulo Ribeirão Preto SP Brazil.
  • Clososki GC; Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Departamento de Ciências Farmacêuticas, Universidade de São Paulo Ribeirão Preto SP Brazil.
  • Steel PG; Department of Chemistry, University of Durham South Road Durham DH1 3LE UK p.g.steel@durham.ac.uk.
RSC Adv ; 13(49): 34391-34399, 2023 Nov 22.
Article em En | MEDLINE | ID: mdl-38024964
Heterocycles are a cornerstone of fragment-based drug discovery (FBDD) due to their prevalence in biologically active compounds. However, novel heterocyclic fragments are only valuable if they can be suitably elaborated to compliment a chosen target protein. Here we describe the synthesis of 5-halo-1H-pyrazolo[3,4-c]pyridine scaffolds and demonstrate how these compounds can be selectively elaborated along multiple growth-vectors. Specifically, N-1 and N-2 are accessed through protection-group and N-alkylation reactions; C-3 through tandem borylation and Suzuki-Miyaura cross-coupling reactions; C-5 through Pd-catalysed Buchwald-Hartwig amination; and C-7 through selective metalation with TMPMgCl.LiCl followed by reaction with electrophiles or transmetalation to ZnCl2 and Negishi cross-coupling. Linking multiple functionalisation strategies emulates a hit-to-lead pathway and demonstrates the utility of pyrazolo[3,4-c]pyridines to FBDD.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: RSC Adv Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: RSC Adv Ano de publicação: 2023 Tipo de documento: Article